Physician profile
Devan Patel
NPI 1033566971
$16,055.63
in general payments reported to CMS, 2019-2025
12 companies · $76.22 in 2025
The $76.22 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $735 · 2021: $1,677 · 2022: $2,059 · 2023: $11K · 2025: $76.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $1,187.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2023 | |
| Axogen | $1,568.15 | 2022-2023 | Avance Nerve Graft |
| Medical Device Business Services, INC. | $1,534.97 | 2019-2022 | |
| Stryker Corporation | $1,520.39 | 2019-2025 | Gamma |
| Zimmer Biomet Holdings, INC. | $469.90 | 2020-2021 | |
| Trimed, INC. | $303.96 | 2023 | |
| Acumed LLC | $289.48 | 2023 | Acumed |
| Globus Medical, INC. | $144.53 | 2023 | Mini Fragment System |
| Smith+Nephew, INC. | $93.95 | 2022 | |
| Evolution Surgical, INC | $77.63 | 2023-2025 | |
| Integra Lifesciences Corporation | $35.52 | 2019 | |
| Bioventus LLC | $17.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.